- Product Details
Keywords
- Sunitinib
- 557795-19-4
- C26H31FN4O6
Quick Details
- ProName: lower price Sunitinib(557795-19-4) su...
- CasNo: 557795-19-4
- Molecular Formula: C26H31FN4O6
- Appearance: white powder
- Application: used for research
- DeliveryTime: 3 days
- PackAge: aluminum foil bag
- Port: shenzhen
- ProductionCapacity: 1 Metric Ton/Day
- Purity: 99%min
- Storage: Store in cool, dry, ventilated place
- Transportation: by sea or by air
- LimitNum: 1 Gram
- Related Substances: N/A
- Residue on Ignition: N/A
- Heavy Metal: N/A
- Valid Period: one year
- N/A: N/A
Superiority
www.wolcase.com
6.We can help our regular clients to suggest some vials factories which produce different size vials(2ml, 5ml, 7ml, 10ml, 20ml...), hoping can bring you convenience if you need these vials, too.
Details
-
Product Name: Sunitinib Synonyms: sunitinib;SUNITINIB-D4;SUNITINIB MALEATE;n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide;SUNITINIB BASE;1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;SUNITINIBMALEATE(FORR&DONLY);N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)meth yl]-2,4-dimethyl-1H-pyrrole-3-carboxamide CAS: 557795-19-4 MF: C26H31FN4O6 MW: 514.55 EINECS: Product Categories: Active Pharmaceutical Ingredients;Sunitinib;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tyrosine Kinase Inhibitors;Pharmaceutical intermediate;API;Isotope Labelled Compounds;SU-11248 Mol File: 557795-19-4.mol Sunitinib Structure Sunitinib Chemical Properties mp 189-191°C CAS DataBase Reference 557795-19-4(CAS DataBase Reference) Safety Information MSDS Information Sunitinib Usage And Synthesis Chemical Properties Yellow Solid Usage A multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic Usage Sunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit. Usage Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit. Usage Labelled Sunitinib (S820000), a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK).